Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanotubes, Carbon | 10 | 2017 | 23 | 2.990 |
Why?
|
Silver | 4 | 2021 | 8 | 2.770 |
Why?
|
Metal Nanoparticles | 4 | 2021 | 14 | 2.760 |
Why?
|
Breast Neoplasms | 8 | 2021 | 666 | 1.720 |
Why?
|
Hyperthermia, Induced | 6 | 2021 | 235 | 1.250 |
Why?
|
Exosomes | 7 | 2021 | 38 | 1.150 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 546 | 1.140 |
Why?
|
Cell Survival | 8 | 2021 | 272 | 1.090 |
Why?
|
Cell Line, Tumor | 17 | 2021 | 681 | 0.980 |
Why?
|
Genetic Vectors | 11 | 2009 | 118 | 0.860 |
Why?
|
Adenoviridae | 9 | 2009 | 61 | 0.860 |
Why?
|
Radiation, Ionizing | 1 | 2021 | 22 | 0.790 |
Why?
|
Nanoparticles | 5 | 2021 | 48 | 0.780 |
Why?
|
Phototherapy | 3 | 2016 | 47 | 0.740 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2021 | 15 | 0.730 |
Why?
|
Acridines | 2 | 2017 | 19 | 0.730 |
Why?
|
Drug Delivery Systems | 3 | 2016 | 92 | 0.730 |
Why?
|
Cell Culture Techniques | 2 | 2018 | 165 | 0.730 |
Why?
|
Platinum | 2 | 2017 | 19 | 0.720 |
Why?
|
Molecular Imaging | 2 | 2019 | 22 | 0.670 |
Why?
|
Gene Transfer Techniques | 8 | 2018 | 69 | 0.660 |
Why?
|
Carbocyanines | 1 | 2018 | 3 | 0.640 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2015 | 25 | 0.630 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 45 | 0.620 |
Why?
|
MicroRNAs | 4 | 2021 | 173 | 0.580 |
Why?
|
Prostatic Neoplasms | 5 | 2019 | 441 | 0.580 |
Why?
|
bcl-X Protein | 1 | 2016 | 6 | 0.580 |
Why?
|
Animals | 29 | 2021 | 7299 | 0.570 |
Why?
|
Alternative Splicing | 1 | 2016 | 28 | 0.570 |
Why?
|
Carbohydrates | 1 | 2015 | 6 | 0.540 |
Why?
|
Endothelial Cells | 1 | 2017 | 179 | 0.540 |
Why?
|
Mice | 25 | 2021 | 2370 | 0.510 |
Why?
|
Neoplasms | 4 | 2013 | 611 | 0.490 |
Why?
|
Humans | 34 | 2021 | 29123 | 0.440 |
Why?
|
Nanomedicine | 2 | 2009 | 17 | 0.430 |
Why?
|
Lipid Bilayers | 2 | 2008 | 6 | 0.410 |
Why?
|
Female | 19 | 2021 | 18173 | 0.390 |
Why?
|
Graft Rejection | 1 | 2011 | 149 | 0.370 |
Why?
|
Tissue Donors | 1 | 2011 | 167 | 0.360 |
Why?
|
Enterovirus | 3 | 2008 | 3 | 0.350 |
Why?
|
Bone Neoplasms | 2 | 2021 | 104 | 0.330 |
Why?
|
Infrared Rays | 3 | 2021 | 18 | 0.330 |
Why?
|
Nanotechnology | 1 | 2008 | 15 | 0.330 |
Why?
|
Virus Assembly | 1 | 2008 | 12 | 0.330 |
Why?
|
Viral Envelope Proteins | 1 | 2008 | 15 | 0.330 |
Why?
|
Coated Materials, Biocompatible | 1 | 2008 | 17 | 0.330 |
Why?
|
Plasmids | 2 | 2005 | 48 | 0.330 |
Why?
|
DNA | 2 | 2005 | 204 | 0.290 |
Why?
|
Kidney Transplantation | 1 | 2011 | 352 | 0.290 |
Why?
|
Apoptosis | 2 | 2021 | 337 | 0.290 |
Why?
|
Cations | 2 | 2021 | 9 | 0.270 |
Why?
|
Cell Death | 3 | 2021 | 71 | 0.270 |
Why?
|
Hypertension | 1 | 2011 | 910 | 0.240 |
Why?
|
Tissue Distribution | 3 | 2016 | 55 | 0.240 |
Why?
|
Cell Proliferation | 5 | 2018 | 573 | 0.240 |
Why?
|
Promoter Regions, Genetic | 4 | 2016 | 212 | 0.210 |
Why?
|
Up-Regulation | 3 | 2018 | 183 | 0.210 |
Why?
|
Mice, Inbred BALB C | 6 | 2013 | 160 | 0.210 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 81 | 0.200 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 525 | 0.180 |
Why?
|
Phenylthiohydantoin | 1 | 2019 | 4 | 0.180 |
Why?
|
Qa-SNARE Proteins | 1 | 2019 | 4 | 0.180 |
Why?
|
Genetic Engineering | 3 | 2009 | 19 | 0.180 |
Why?
|
Indicators and Reagents | 2 | 2018 | 15 | 0.180 |
Why?
|
Protein Binding | 2 | 2017 | 199 | 0.180 |
Why?
|
Phenotype | 2 | 2019 | 629 | 0.170 |
Why?
|
Proteome | 1 | 2019 | 34 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 249 | 0.170 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 158 | 0.160 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 208 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 19 | 0.160 |
Why?
|
Microfilament Proteins | 1 | 2018 | 33 | 0.160 |
Why?
|
Molecular Probes | 1 | 2018 | 15 | 0.160 |
Why?
|
Cytological Techniques | 1 | 2018 | 19 | 0.160 |
Why?
|
Proteomics | 1 | 2019 | 92 | 0.160 |
Why?
|
Microglia | 1 | 2018 | 48 | 0.160 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2018 | 18 | 0.160 |
Why?
|
Staining and Labeling | 1 | 2018 | 56 | 0.160 |
Why?
|
Mice, Nude | 5 | 2021 | 276 | 0.160 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2017 | 2 | 0.160 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 72 | 0.160 |
Why?
|
Cells, Cultured | 4 | 2017 | 799 | 0.150 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 67 | 0.150 |
Why?
|
Placenta | 1 | 2018 | 63 | 0.150 |
Why?
|
Plastics | 1 | 2017 | 2 | 0.150 |
Why?
|
Basement Membrane | 1 | 2017 | 7 | 0.150 |
Why?
|
Silicon Dioxide | 1 | 2017 | 8 | 0.150 |
Why?
|
Coordination Complexes | 1 | 2017 | 6 | 0.150 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 68 | 0.150 |
Why?
|
Drug Carriers | 1 | 2017 | 16 | 0.150 |
Why?
|
Microvessels | 1 | 2017 | 23 | 0.150 |
Why?
|
Molecular Probe Techniques | 1 | 2016 | 4 | 0.150 |
Why?
|
Benzamides | 1 | 2016 | 54 | 0.140 |
Why?
|
RNA Precursors | 1 | 2016 | 2 | 0.140 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 2 | 0.140 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 11 | 0.140 |
Why?
|
Mitochondria | 1 | 2018 | 174 | 0.140 |
Why?
|
RNA, Messenger | 3 | 2016 | 514 | 0.140 |
Why?
|
Macrophages, Alveolar | 4 | 2000 | 9 | 0.140 |
Why?
|
Ethylenediamines | 1 | 2016 | 6 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 106 | 0.140 |
Why?
|
Protein Isoforms | 1 | 2016 | 56 | 0.140 |
Why?
|
Chelating Agents | 1 | 2016 | 17 | 0.140 |
Why?
|
Zinc | 1 | 2016 | 32 | 0.140 |
Why?
|
Base Sequence | 1 | 2016 | 240 | 0.140 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 172 | 0.130 |
Why?
|
Transcription, Genetic | 1 | 2016 | 136 | 0.130 |
Why?
|
Stem Cells | 1 | 2018 | 292 | 0.130 |
Why?
|
Melanoma | 1 | 2016 | 148 | 0.130 |
Why?
|
Estrogens | 1 | 2016 | 162 | 0.130 |
Why?
|
Mice, Inbred C57BL | 9 | 2018 | 711 | 0.130 |
Why?
|
African Americans | 2 | 2019 | 1373 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2017 | 33 | 0.120 |
Why?
|
Electroporation | 1 | 2013 | 14 | 0.120 |
Why?
|
Brain | 2 | 2018 | 930 | 0.110 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2012 | 3 | 0.110 |
Why?
|
Hot Temperature | 1 | 2012 | 71 | 0.110 |
Why?
|
Gene Expression | 5 | 2000 | 332 | 0.100 |
Why?
|
Male | 8 | 2019 | 17815 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 90 | 0.100 |
Why?
|
Time Factors | 2 | 2013 | 2001 | 0.100 |
Why?
|
Cadaver | 1 | 2011 | 143 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 337 | 0.100 |
Why?
|
Creatinine | 1 | 2011 | 174 | 0.100 |
Why?
|
Kidney Neoplasms | 2 | 2011 | 192 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2001 | 61 | 0.090 |
Why?
|
DNA, Complementary | 6 | 2000 | 33 | 0.090 |
Why?
|
Iron | 1 | 2011 | 113 | 0.090 |
Why?
|
Electrochemotherapy | 1 | 2010 | 3 | 0.090 |
Why?
|
Needles | 1 | 2010 | 28 | 0.090 |
Why?
|
Iron Chelating Agents | 1 | 2009 | 8 | 0.090 |
Why?
|
Capsid Proteins | 1 | 2009 | 7 | 0.090 |
Why?
|
Capsid | 1 | 2009 | 9 | 0.090 |
Why?
|
Cyclic AMP | 3 | 1998 | 40 | 0.090 |
Why?
|
Survival Rate | 1 | 2011 | 795 | 0.080 |
Why?
|
Models, Molecular | 1 | 2009 | 178 | 0.080 |
Why?
|
Viremia | 1 | 2008 | 5 | 0.080 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 6 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 2 | 2005 | 7 | 0.080 |
Why?
|
Biomedical Engineering | 1 | 2008 | 23 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 76 | 0.080 |
Why?
|
Thrombopoietin | 2 | 1998 | 4 | 0.080 |
Why?
|
Injections, Intravenous | 2 | 2006 | 73 | 0.080 |
Why?
|
Materials Testing | 1 | 2008 | 84 | 0.080 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1997 | 10 | 0.080 |
Why?
|
Cohort Studies | 1 | 2011 | 1688 | 0.070 |
Why?
|
Prostate | 2 | 2018 | 68 | 0.070 |
Why?
|
Indium Radioisotopes | 1 | 2006 | 1 | 0.070 |
Why?
|
Pentetic Acid | 1 | 2006 | 2 | 0.070 |
Why?
|
Half-Life | 1 | 2006 | 22 | 0.070 |
Why?
|
Molecular Structure | 1 | 2006 | 53 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 3 | 2001 | 27 | 0.070 |
Why?
|
Surface Plasmon Resonance | 1 | 2005 | 6 | 0.070 |
Why?
|
Lysine | 1 | 2005 | 24 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2005 | 92 | 0.070 |
Why?
|
Platelet Count | 2 | 2011 | 21 | 0.060 |
Why?
|
Pseudomonas Infections | 2 | 2001 | 9 | 0.060 |
Why?
|
Signal Transduction | 2 | 2018 | 666 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2001 | 47 | 0.060 |
Why?
|
European Continental Ancestry Group | 2 | 2019 | 1131 | 0.060 |
Why?
|
Treatment Outcome | 1 | 2011 | 3101 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2021 | 425 | 0.060 |
Why?
|
Retrospective Studies | 1 | 2011 | 3112 | 0.060 |
Why?
|
Receptors, Virus | 2 | 2000 | 15 | 0.050 |
Why?
|
Cell Division | 2 | 2001 | 97 | 0.050 |
Why?
|
Particle Size | 2 | 2017 | 42 | 0.050 |
Why?
|
Osteoclasts | 1 | 2021 | 22 | 0.050 |
Why?
|
Bacterial Vaccines | 1 | 2001 | 7 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2016 | 223 | 0.050 |
Why?
|
Genes, Reporter | 2 | 1998 | 37 | 0.050 |
Why?
|
Virus Replication | 2 | 1999 | 47 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2021 | 89 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2000 | 13 | 0.050 |
Why?
|
Temperature | 2 | 2012 | 55 | 0.050 |
Why?
|
Lung | 2 | 1999 | 233 | 0.050 |
Why?
|
Pulmonary Edema | 1 | 2000 | 7 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 199 | 0.050 |
Why?
|
Lymphokines | 1 | 2000 | 10 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 12 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2000 | 18 | 0.050 |
Why?
|
Vaccination | 1 | 2001 | 123 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 90 | 0.050 |
Why?
|
Receptors, IgG | 1 | 1999 | 7 | 0.040 |
Why?
|
Receptors, HIV | 1 | 1999 | 1 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 1999 | 9 | 0.040 |
Why?
|
HIV-1 | 1 | 1999 | 42 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 90 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 24 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 42 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 57 | 0.040 |
Why?
|
Genome, Viral | 1 | 1998 | 12 | 0.040 |
Why?
|
Transfection | 1 | 1999 | 192 | 0.040 |
Why?
|
Adult | 1 | 2011 | 8426 | 0.040 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2018 | 3 | 0.040 |
Why?
|
Benzylidene Compounds | 1 | 2018 | 6 | 0.040 |
Why?
|
Cholesterol | 1 | 2000 | 229 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2018 | 25 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2019 | 101 | 0.040 |
Why?
|
Chimera | 1 | 1998 | 8 | 0.040 |
Why?
|
Down-Regulation | 1 | 2018 | 143 | 0.040 |
Why?
|
Sulfenic Acids | 1 | 2018 | 52 | 0.040 |
Why?
|
Biopsy | 1 | 2019 | 241 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 1997 | 23 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 189 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 250 | 0.040 |
Why?
|
Surface Properties | 1 | 2017 | 32 | 0.040 |
Why?
|
Macrophages | 1 | 2019 | 188 | 0.040 |
Why?
|
Porosity | 1 | 2017 | 36 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2019 | 519 | 0.040 |
Why?
|
Middle Aged | 1 | 2011 | 10834 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 66 | 0.040 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 17 | 0.040 |
Why?
|
Phospholipids | 1 | 2017 | 27 | 0.040 |
Why?
|
Isotope Labeling | 1 | 2016 | 17 | 0.040 |
Why?
|
Calcium | 1 | 2019 | 297 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 66 | 0.040 |
Why?
|
Lipids | 1 | 2018 | 209 | 0.040 |
Why?
|
Organ Specificity | 1 | 2016 | 77 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2019 | 153 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1996 | 18 | 0.040 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2016 | 6 | 0.040 |
Why?
|
Aptamers, Nucleotide | 1 | 2016 | 9 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2016 | 19 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 88 | 0.040 |
Why?
|
Liposomes | 1 | 2016 | 26 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 394 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 815 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 481 | 0.030 |
Why?
|
Liver | 1 | 1998 | 464 | 0.030 |
Why?
|
Prognosis | 1 | 2018 | 1362 | 0.030 |
Why?
|
Tumor Burden | 1 | 2013 | 60 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2013 | 43 | 0.030 |
Why?
|
Thermography | 1 | 2012 | 2 | 0.030 |
Why?
|
Absorption | 1 | 2012 | 15 | 0.030 |
Why?
|
Cell Line | 3 | 1999 | 450 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2012 | 56 | 0.030 |
Why?
|
Laser Therapy | 1 | 2012 | 52 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 8 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2012 | 14 | 0.030 |
Why?
|
Necrosis | 1 | 2012 | 53 | 0.030 |
Why?
|
Platelet Activation | 1 | 2011 | 12 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 2011 | 17 | 0.030 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 17 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 152 | 0.020 |
Why?
|
Thrombosis | 1 | 2011 | 60 | 0.020 |
Why?
|
Contrast Media | 1 | 2011 | 124 | 0.020 |
Why?
|
Survival Analysis | 1 | 2012 | 440 | 0.020 |
Why?
|
Electrodes | 1 | 2010 | 16 | 0.020 |
Why?
|
Siderophores | 1 | 2009 | 1 | 0.020 |
Why?
|
Iron Overload | 1 | 2009 | 37 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 113 | 0.020 |
Why?
|
United States | 1 | 2018 | 3632 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 28 | 0.020 |
Why?
|
Luminescent Proteins | 2 | 1999 | 24 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2009 | 62 | 0.020 |
Why?
|
Green Fluorescent Proteins | 2 | 1999 | 71 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1999 | 248 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 1219 | 0.020 |
Why?
|
Ethylene Glycols | 1 | 2004 | 8 | 0.020 |
Why?
|
CHO Cells | 1 | 2004 | 25 | 0.020 |
Why?
|
Carbon | 1 | 2004 | 10 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2004 | 13 | 0.020 |
Why?
|
Cricetinae | 1 | 2004 | 58 | 0.020 |
Why?
|
Hela Cells | 1 | 2004 | 78 | 0.020 |
Why?
|
Rats | 2 | 1999 | 1604 | 0.020 |
Why?
|
Cell Membrane | 1 | 2004 | 98 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2001 | 31 | 0.010 |
Why?
|
Immunization | 1 | 2000 | 28 | 0.010 |
Why?
|
Evans Blue | 1 | 2000 | 1 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 12 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 74 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2000 | 7 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 2000 | 19 | 0.010 |
Why?
|
Capillary Permeability | 1 | 2000 | 15 | 0.010 |
Why?
|
Transgenes | 1 | 2000 | 45 | 0.010 |
Why?
|
Water | 1 | 2000 | 50 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2000 | 69 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2000 | 92 | 0.010 |
Why?
|
Coloring Agents | 1 | 2000 | 30 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2000 | 12 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 2000 | 7 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2000 | 103 | 0.010 |
Why?
|
Opsonin Proteins | 1 | 1999 | 3 | 0.010 |
Why?
|
Phagocytes | 1 | 1999 | 5 | 0.010 |
Why?
|
Phagocytosis | 1 | 1999 | 9 | 0.010 |
Why?
|
Receptors, CCR3 | 1 | 1999 | 1 | 0.010 |
Why?
|
Chemokine CCL4 | 1 | 1999 | 4 | 0.010 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 1999 | 3 | 0.010 |
Why?
|
Chemokine CCL5 | 1 | 1999 | 6 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 1999 | 3 | 0.010 |
Why?
|
Chemokine CCL3 | 1 | 1999 | 6 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 1999 | 11 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2000 | 55 | 0.010 |
Why?
|
Macrophage Activation | 1 | 1999 | 9 | 0.010 |
Why?
|
Erythrocytes | 1 | 1999 | 43 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1999 | 16 | 0.010 |
Why?
|
Fibroblasts | 1 | 2000 | 103 | 0.010 |
Why?
|
Cytokines | 1 | 2000 | 243 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1999 | 51 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1999 | 81 | 0.010 |
Why?
|
Sheep | 1 | 1999 | 221 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1999 | 67 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 18 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1999 | 172 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1999 | 138 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1998 | 42 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 84 | 0.010 |
Why?
|
Avian Sarcoma Viruses | 1 | 1998 | 1 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 6 | 0.010 |
Why?
|
Luciferases | 1 | 1998 | 27 | 0.010 |
Why?
|
Anions | 1 | 1997 | 2 | 0.010 |
Why?
|
Chlorides | 1 | 1997 | 15 | 0.010 |
Why?
|
Megakaryocytes | 1 | 1997 | 4 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1997 | 14 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1997 | 20 | 0.010 |
Why?
|
Spleen | 1 | 1997 | 82 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1997 | 95 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1997 | 114 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1998 | 747 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1996 | 142 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1996 | 384 | 0.010 |
Why?
|